Global Health Limited · NSE:MEDANTA
Global Health — Q3 FY2024 Earnings Presentation
27 slides from Global Health's earnings presentation, Feb 8, 2024
Slide 1: Exchange filing cover letter
February 8, 2024 Ref:- GHL/2023-24/EXCH/99 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051
Slide 2: Global Health Limited Investor Presentation Q3 and 9M FY2024
GLOBAL HEALTH LIMITED Dedicated to Life INVESTOR PRESENTATION 5 Q3 and 9M FY2024 1
Slide 3: Contents
Contents 01 Q3 and 9M FY2024 Performance Update 02 Medanta: Poised to Deliver Sustainable Growth 03 About Us 2
Slide 4: Q3 and 9M FY2024 Performance Update
01 Q3 and 9M FY2024 Performance Update 3
Slide 5: Q3 FY2024 performance summary
Q3 FY2024 performance summary Robust performance during the quarter driven by growth in patient volumes and realization INR 8,545 million INR 2,340 million INR 1,235 million Total Income EBITDA and Margins % Margins % PAT and Margin: 27.4% Margin: 14.5% Q3 FY23 Q3 FY23 Q3 FY23 7,062 million 21% 1,71
Slide 6: Q3 FY2024 performance summary
Q3 FY2024 performance summary Matured and Developing Hospitals reported strong y-o-y revenue growth of 17% and 33% in Q3 FY24 Consolidated Total Income of INR 8,545 million, grew by 21% y-o-y. The growth was driven by higher patient volumes across all our facilities and realization growth at Gurugra
Slide 7: Q3 FY2024 clinical achievements
Q3 FY2024 clinical achievements Continuing the legacy of clinical excellence Medanta Gurugram became the first hospital in India to use advanced AI-enabled penumbra lightning technology for treating pulmonary embolism and other blood clots A multidisciplinary team at Medanta Gurugram saved life of a
Slide 8: Key operating metrics: Revenue and profitability
Key operating metrics: Revenue and profitability Robust growth across all major metrics Total Income (INR million) EBITDA (INR million and margin %) +24% +37% 25,137 6,670 +21% 20,273 +36% 8,647 8,545 4,856 7,062 2,336 2,340 1,719 9M FY23 9M FY24 Q3 FY23 Q2 FY24 Q3 FY24 9M FY23 9M FY24 Q3 FY23 Q2 FY
Slide 9: Key operating metrics: Volumes, occupancies, ALOS
Key operating metrics: Volumes, occupancies, ALOS Strong growth on a y-o-y basis driven by increase in patient volumes Average census and occupied beds per day ALOS (days) 2,223 2,111 2,223 2,223 2,019 3.24 3.21 3.26 3.19 3.30 1,387 1,442 1,427 1,194 1,247 9M FY23 9M FY24 Q3 FY23 Q2 FY24 Q3 FY24 9M
Slide 10: Key operating metrics: ARPOB and revenue mix
Key operating metrics: ARPOB and revenue mix ARPOB growth driven by improved realizations at Gurugram ARPOB1 (INR) IPD Revenue mix by payor category2 +5% +4% 58,494 61,515 58,367 61,003 60,571 63% 61% 64% 61% 61% 9% 9% 8% 9% 9% 24% 3% 24% 23% 3% 24% 24% 4% 4% 4% 2% 2% 2% 2% 2% 9M FY23 9M FY24 Q3 FY2
Slide 11: Diverse revenue mix
Diverse revenue1 mix Significant contribution from complex specialties Heart 23.2% 23.0% 22.8% 23.0% 22.2% Digestive 12.0% 11.5% 12.2% 11.7% 11.2% Cancer 11.8% 12.0% 11.5% 12.0% 12.3% Neuro 11.4% 11.2% 11.0% 11.1% 11.4% Kidney & Urology 7.4% 7.7% 7.4% 7.6% 7.5% Internal Medicine 6.9% 6.2% 7.6% 6.2%
Slide 12: Growth seen in both mature and new hospitals
Growth seen in both mature and new hospitals Volume led growth seen across all units Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million and margin %) +17% +37% +33% +51%
Slide 13: Medanta Poised to Deliver Sustainable Growth
Medanta Poised to Deliver Sustainable Growth 02 Values based growth you can be proud of 12
Slide 14: Medanta is well placed to deliver sustainable growth
Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro
Slide 15: On-going expansion projects on track for FY2025
On-going expansion projects on track for FY2025 Planned bed capacity addition; well positioned to drive near term growth Number of installed beds Planned growth in number of installed beds 293 2,697 28 2,725 300-550 ~3,500-4,000 191 228 102 150-300 300-350 419 35 2,725 ~100 1,722 410 9 FY 19 FY 20 F
Slide 16: Medanta and DLF to develop ~400 beds hospital in Delhi
Medanta and DLF to develop ~400 beds super-specialty hospital in Delhi Further strengthening NCR presence; linking Gurugram and Noida with its new South Delhi facility • Plan to set up a ~400-bed super specialty hospital in South Delhi • SPV named “GHL Hospital Limited” was formed in December 2023 •
Slide 17: Noida Hospital Update
Noida Hospital Update Noida construction in full swing with 82% superstructure completion • Project situated in sector 50 Noida, close proximity to metro station • Greenfield project, with bed capacity of 550 beds • Construction started in September 2022 • Mechanical Electrical and Plumbing work in
Slide 18: About Us
03 About Us 17
Slide 19: Medanta was founded to bring a new type of healthcare to India
Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec
Slide 20: Growth from a single flagship hospital to a network of 5 hospitals
Growth from a single flagship hospital in Gurgaon… …to a network of 5 high quality hospitals across north India 2025E MEDANTA HOSPITAL 2021 NOIDA JAI PRABHA Plan for 550 beds 2019 MEDANTA SPECIALTY Expected to MEDANTA HOSPITAL begin phase I 2015 HOSPITAL PATNA operations with MEDANTA ABDUR LUCKNOW ~
Slide 21: One of the largest private hospital chains in North and East India
One of the largest private hospital chains in North and East India Infrastructure and High quality Awards and technology clinical talent accreditations Built to deliver the Full time doctors; National and international most complex care team based care recognition Network of 5 multi- 1,600+ doctors*
Slide 22: From our flagship Medicity campus, we have grown to ~2,700 beds
From our flagship Medicity campus in Gurgaon, we have grown to ~2,700 beds across 5 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar GURGAON LUCKNOW PATNA 1,391 beds; 271 ICU beds 601 beds; 202 ICU beds (950 planned) 358 beds; 84 ICU beds (650
Slide 23: Our Mission and Values
Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla
Slide 24: Annexure: Profit and Loss Statement
Annexure: Profit and Loss Statement Nine Months Quarter INR million 9M FY23 9M FY24 Y-o-Y Growth % Q3 FY23 Q2 FY24 Q3 FY24 Y-o-Y Growth % Revenue from operations 19,908 24,496 23.0% 6,943 8,439 8,326 19.9% Other income 365 641 75.7% 119 208 219 84.2% Total income 20,273 25,137 24.0% 7,062 8,647 8,54
Slide 25: Annexure: Operational Parameters
Annexure: Operational Parameters Nine Months Quarter Key metrics 9M FY23 9M FY24 Y-o-Y Growth % Q3 FY23 Q2 FY24 Q3 FY24 Y-o-Y Growth % Total Beds 2,571 2,725 6.0% 2,571 2,725 2,725 6.0% Average Census Beds 2,019 2,223 10.1% 2,111 2,223 2,223 5.3% Average Occupied Bed Days 328,253 381,405 16.2% 114,6
Slide 26: Annexure: Abbreviations and Definitions
Annexure: Abbreviations and Definitions Abbreviations INR : Indian Rupee NABH : National Accreditation Board for Hospitals & Healthcare Providers NABL : National Accreditation Board for Testing and Calibration Laboratories JCI : Joint Commission International OPD : Out-Patient Department
Slide 27: Contact us
Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a